These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21252015)

  • 1. Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
    Silber S; Damman P; Klomp M; Beijk MA; Grisold M; Ribeiro EE; Suryapranata H; Wójcik J; Hian Sim K; Tijssen JG; de Winter RJ
    EuroIntervention; 2011 Feb; 6(7):819-25. PubMed ID: 21252015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registry.
    Scacciatella P; Meliga E; D'Amico M; Amato G; Pennone M; Conrotto F; Marra S
    EuroIntervention; 2011 Feb; 6(7):826-30. PubMed ID: 21252016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous™ bio-engineered R stent™ in patients from the e-HEALING registry.
    Damman P; Klomp M; Silber S; Beijk MA; Ribeiro EE; Suryapranata H; Wójcik J; Sim KH; Tijssen JG; de Winter RJ;
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):243-52. PubMed ID: 21542121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry.
    Beijk MA; Damman P; Klomp M; Woudstra P; Silber S; Grisold M; Ribeiro EE; Suryapranata H; Wójcik J; Sim KH; Tijssen JG; de Winter AR;
    Coron Artery Dis; 2012 May; 23(3):201-7. PubMed ID: 22487946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
    Klomp M; Damman P; Beijk MA; Silber S; Grisold M; Ribeiro EE; Suryapranata H; Wòjcik J; Sim KH; Tijssen JG; de Winter RJ;
    Heart Vessels; 2012 Jul; 27(4):360-9. PubMed ID: 21725668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.
    Aoki J; Serruys PW; van Beusekom H; Ong AT; McFadden EP; Sianos G; van der Giessen WJ; Regar E; de Feyter PJ; Davis HR; Rowland S; Kutryk MJ
    J Am Coll Cardiol; 2005 May; 45(10):1574-9. PubMed ID: 15893169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry.
    Damman P; Klomp M; Beijk MA; Silber S; Grisold M; Ribeiro EE; Suryapranata H; Wójcik J; Sim KH; Tijssen JG; DE Winter RJ;
    J Interv Cardiol; 2011 Aug; 24(4):285-94. PubMed ID: 21281358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
    J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
    Martin-Yuste V; Brugaletta S; Ferreira-González I; Cola C; Alvarez-Contreras L; de Antonio M; Martí V; García-Picart J; Sabaté M
    EuroIntervention; 2011 Feb; 6(7):831-7. PubMed ID: 21252017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients.
    den Dekker WK; Houtgraaf JH; Onuma Y; Benit E; de Winter RJ; Wijns W; Grisold M; Verheye S; Silber S; Teiger E; Rowland SM; Ligtenberg E; Hill J; Wiemer M; den Heijer P; Rensing BJ; Channon KM; Serruys PW; Duckers HJ
    Atherosclerosis; 2011 Nov; 219(1):245-52. PubMed ID: 21763653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genous endothelial progenitor cell-capturing stent system: a novel stent technology.
    Klomp M; Beijk MA; de Winter RJ
    Expert Rev Med Devices; 2009 Jul; 6(4):365-75. PubMed ID: 19572791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
    Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
    J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
    Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
    J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant intimal hyperplasia regression between 6 and 18 months following Genous™ endothelial progenitor cell capturing stent placement.
    Klomp M; Beijk MA; Tijssen JG; de Winter RJ
    Int J Cardiol; 2011 Mar; 147(2):289-91. PubMed ID: 21194767
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial progenitor cell capture stent: safety and effectiveness.
    Sethi R; Lee CH
    J Interv Cardiol; 2012 Oct; 25(5):493-500. PubMed ID: 22612275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.
    Tamburino C; Capodanno D; La Manna A; di Salvo M; Sanfilippo A; Prati F
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):53-8. PubMed ID: 19829136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.